Press Releases

Our medical news may contain information about Shionogi products and is therefore intended for medical journalists and health care professionals only. By clicking through to see medical news, you are confirming that you are a medical journalist or healthcare professional.

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

April

08 Apr 2025 Release Medical News
ESCMID Global 2025: Shionogi presents real-world data demonstrating better clinical outcomes when Fetcroja® / Fetroja® (cefiderocol) is used as empiric or documented therapy as compared to salvage therapy for the treatment of Gram-negative bacterial infections

March

13 Mar 2025 Release Medical News
SCORPIO-PEP Phase 3 Trial: Ensitrelvir is the first and only COVID-19 oral antiviral to demonstrate prevention of COVID-19 as post exposure prophylaxis

January

30 Jan 2025 Release Medical News
Shionogi Announces Positive Results from Phase 2 Human Challenge Trial of Respiratory Syncytial Virus (RSV) Oral Antiviral Candidate S-337395

Select Year

NP-EU-NP-0260 | June 2024